Who makes Oxycodone API powder?

Oxycodone API powder is developed by Grünenthal GmbH.

What development phase is Oxycodone API powder in?

Oxycodone API powder is in Phase 1.

Last reviewed 2026-04-19 · How we verify

Oxycodone API powder

Grünenthal GmbH · Phase 1 active Small molecule

At a glance

Generic name	Oxycodone API powder
Sponsor	Grünenthal GmbH
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Comparison of How Likely it is That Different Tablets of Oxycodone Will be Broken up and Snorted by Adults Who Sometimes Take Drugs for Pleasure (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Oxycodone API powder CI brief — competitive landscape report
Oxycodone API powder updates RSS · CI watch RSS
Grünenthal GmbH portfolio CI